West Virginia 2026 Regular Session

West Virginia House Bill HB5103

Introduced
2/3/26  

Caption

Relating to requiring the Office of Health Facility Licensure and Certification to inspect office-based medication-assisted treatment programs at least every 24 months

Summary

House Bill 5103 would amend West Virginia’s Medication-Assisted Treatment Program Licensing Act to require the Office of Health Facility Licensure and Certification to inspect office-based medication-assisted treatment programs at least once every 24 months. The bill keeps the existing requirement for annual inspections of opioid treatment programs, but adds a formal biennial inspection schedule for office-based MAT programs, along with patient-record review to assess compliance with state law and applicable rules. The bill also preserves the agency’s authority to conduct unannounced complaint and verification inspections of office-based programs, to document and verify corrective actions, and to seek inspection warrants when necessary. It further states that, when possible, inspections for annual certification and licensure should be done consecutively or concurrently, while making clear that this does not limit complaint-driven inspections.

Impact

If enacted, the bill would create a clearer minimum inspection cadence for office-based medication-assisted treatment programs and strengthen oversight of those providers under state law. It would affect the Office of Health Facility Licensure and Certification, the Inspector General, program medical directors and owners, and any office-based MAT providers subject to licensure and compliance review. The bill does not change the annual inspection requirement for opioid treatment programs, but it would formalize a separate 24-month inspection standard for office-based MAT programs.

Sentiment

The available record shows no committee transcript, vote tally, or recorded opposition, so there is no documented debate to indicate strong support or resistance. Based on the bill’s text and stated purpose, the measure appears to be framed as a regulatory oversight bill aimed at ensuring periodic review of treatment programs rather than a major policy change. The absence of recorded votes or discussion means sentiment cannot be measured directly from the provided materials.

Contention

No specific points of contention are documented in the provided materials. Potential areas of concern, based on the bill’s provisions, could include the administrative burden on providers, the cost and staffing demands of more regular inspections, and the scope of patient-record review during inspections. However, no legislator, agency, provider group, or other stakeholder is identified in the record as having raised these issues.

Companion Bills

No companion bills found.

Previously Filed As

WV HB3096

Relating to requiring the Office of Health Facility Licensure and Certification to inspect office-based medication-assisted treatment programs at least every 24 months

WV HB3385

Requiring medication-assisted treatment prgrams to have written policies concerning community relations

WV SB726

Relating to medication-assisted treatment programs

WV SB333

Office of Inspector General rule relating to hospital licensure

WV SB334

Office of Inspector General rule relating to behavioral health centers licensure

WV HB2349

To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone

WV HB2253

Relating to authorizing the Office of Inspector General to promulgate a legislative rule relating to hospital licensure

WV HB2254

Relating to authorizing the Office of Inspector General to promulgate a legislative rule relating to Behavioral Health Centers Licensure

WV SB649

Supplementing and amending appropriations to Department of Health, Office of Inspector General

WV HB2702

Relating to vacancies in offices of state officials

Similar Bills

No similar bills found.